Multidrug resistant Mycobacterium tuberculosis amongst Category I & II failures and Category II relapse patients from Pakistan

World Health Organization. Global Tuberculosis Control Report 2010. Geneva, Switzerland: WHO, 2010. WHO/HTM/TB/2010.7. World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO, Report 2009. WHO/HTM/TB/2009.411. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): global report on surveillance and response. WHO, Report 2010. WHO/HTM/TB/2010.3. Dye, 2002, Worldwide incidence of multidrug-resistant tuberculosis, J. Infect. Dis., 185, 1197, 10.1086/339818 Rajabhandary, 2004, Costs of patients hospitalized for multi-drug resistant tuberculosis, Int. J. Tuberc. Lung Dis., 8, 1012 Gupta, 2001, Responding to market failure in tuberculosis control, Science, 293, 1049, 10.1126/science.1061861 Aziz, 2006, Global project on anti-tuberculosis drug resistance surveillance; epidemiology of anti-tuberculosis drug resistance: an updated analysis, Lancet, 368, 2142, 10.1016/S0140-6736(06)69863-2 Parmasivan, 2004, Drug resistance in tuberculosis in India, Indian J. Med. Res., 120, 377 Migliori, 2002, Frequency of recurrence among MDR-TB cases successfully treated with standardised short course chemotherapy, Int. J. Tuberc. Lung. Dis., 6, 858 Hasan, 2009, Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990–2007, Int. J. Infect. Dis., 13, 377, 10.1016/j.ijid.2009.01.008 Centers for Disease Control and Prevention, 2006, Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000–2004, Morb. Mortal. Wkly. Rep., 55, 301 Anonymous, 2006, XDR-TB a global threat, Lancet, 368, 964, 10.1016/S0140-6736(06)69391-4 Ejaz, 2010, Prevalence of multi-drug resistance tuberculosis in Karachi Pakistan: identification of at risk groups, Trans. Royal Soc. Trop. Med. Hyg., 104, 511, 10.1016/j.trstmh.2010.03.005 Hasan, 2010, Extensively drug-resistant tuberculosis, Pakistan, Emerg. Infect. Dis., 16, 1473, 10.3201/eid1609.100280 Khyber Pakhtoon Khawah (KP) Pakistan http://www.pakistanpassion.com/static/KhyberPakhtoonKhawah.aspx. World Health Organization. Guideline for National tuberculosis programs on management of tuberculosis. WHO report 2003. WHO/CDS/TB/2003.316. National Committee for Clinical and Laboratory Standards Institute. 2003. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes, second ed., Approved standard M24-A. NCCLS, Wayne, PA. Nolte, 1999 Koneman, 1997 Khoharo, 2009, Rising menace of multidrug resistant Mycobacteria in pulmonary tuberculosis, J. Liaquat. Univ. Med. Health Sci., 8, 96 Irfan, 2006, Assessment of resistance in multi-drug resistant tuberculosis patients, J. Pak. Med. Assoc., 56, 397 Ikram, 2008, Latest pattern of multi-drug resistant tuberculosis in Pakistan, Inf. Dis. J. Pak. Science., 17, 14 Shaikh, 2008, Prevalence of drug resistance in pulmonary tuberculosis, J. Liaquat. Univ. Med. Health Sci., 7, 79, 10.22442/jlumhs.08720149 Hanif, 2009, Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India, Int. J. Tuberc. Lung Dis., 13, 74 Shah, 2002, Study of drug resistance in previously treated tuberculosis patients in Gujarat, India, Int. J. Tuberc. Lung Dis., 6, 1098 Vijay, 2004, Initial drug resistance among tuberculosis patients under DOTS programme in Bangalore city, Indian J. Tuberc., 51, 17 Butt, 2004, Multi-drug resistant tuberculosis in Northern Pakistan, J. Pak. Med. Assoc., 54, 469 Karamat, 1999, Drug resistance in Mycobacterium tuberculosis: a four years’ experience, J. Pak. Med. Assoc., 49, 262 Akhtar, 2007, Drug resistance to tuberculosis in a tertiary care setting in Karachi, J. Pak. Med. Assoc., 57, 282 Yoshiyama, 2010, Risk of relapse and failure after retreatment with the Category II regimen in Nepal, Int. J. Tuberc. Lung Dis., 14, 1418 Rafiq, 2011, Fluoroquinolone resistance amongst Mycobacterium tuberculosis strains from Karachi, Pakistan; data from community based field clinics, Antimicrob. Agents Chemother., 55, 929, 10.1128/AAC.00931-10 Huang, 2005, Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995–2003, J. Antimicrob. Chemother., 56, 1058, 10.1093/jac/dki353 Doung, 2009, Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam, Antimicrob. Agents. Chemother., 53, 4835, 10.1128/AAC.00541-09